Showing results (191-200 of 312) with videos related to
Sort By:
Pageof 32
Cancer Research|August 3, 2007
A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor modelHyun-Jeong Ko, Yeon-Jeong Kim, Yun-Sun Kim, et al.Science (New York, N.Y.)|December 20, 2014
Detection of self-reactive CD8⁺ T cells with an anergic phenotype in healthy individualsYuka Maeda, Hiroyoshi Nishikawa, Daisuke Sugiyama, et al.Plos One|August 12, 2016
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 DiabetesFumitaka Haseda, Akihisa Imagawa, Hiroyoshi Nishikawa, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2010
Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigensAnik L Côté, Peisheng Zhang, Jeremy A O'Sullivan, et al.Immunity|October 6, 2009
Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cellsAkihiko Kitoh, Masahiro Ono, Yoshinori Naoe, et al.The Journal of Experimental Medicine|November 21, 2007
Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal modelKeiji Hirota, Hiroyuki Yoshitomi, Motomu Hashimoto, et al.International Immunology|January 3, 2024
Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell functionYujiro Kidani, Yohko Kitagawa, Masaki Hagiwara, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2017
Ultraviolet B-Induced Maturation of CD11b-Type Langerin<sup>-</sup> Dendritic Cells Controls the Expansion of Foxp3<sup>+</sup> Regulatory T Cells in the SkinSayuri Yamazaki, Mizuyu Odanaka, Akiko Nishioka, et al.Plos One|May 10, 2016
Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced ArthritisSara Tengvall, Tove Eneljung, Pernilla Jirholt, et al.Oncotarget|December 30, 2017
Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cellsMakoto Miyara, Driss Chader, Aude Burlion, et al.Pageof 32